Mainstream

Syndax targets expanded $10b market opportunity with revuforj and niktimvo amid accelerating adoption and guidance for stable expenses

Syndax targets expanded $10B market opportunity with Revuforj and Niktimvo amid accelerating adoption and guidance for stable expenses

Syndax targets expanded $10B market opportunity with Revuforj and Niktimvo amid accelerating adoption and guidance for stable expenses

Post ContentsndxRead More

You might also be interested in reading AVAX Set For ATH? Analysts Predict Explosive Rise To $285.

August 5, 2025
In Mainstream